Skip to main content
    C

    CervoMed Inc. (CRVO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.67
    -0.02 (-1.18%)

    Market Cap: $25.57M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CervoMed Inc. (CRVO) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    CervoMed (CRVO) is expected to report earnings on Mar 11, 2027. In the quarter ended Sep 30, 2026, CervoMed reported EPS of -$0.39, above the -$0.61 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    38%(11/29)
    Avg Surprise
    -2.19%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 11, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.53
    Range-$0.74 - -$0.43
    8 analysts
    Revenue Consensus
    N/A
    RangeN/A
    8 analysts
    Reports May 13, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.27
    Range-$0.45 - -$0.13
    3 analysts
    EPS Revisions
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.35+23.4%
    60d ago-$0.42+35.7%
    30d ago-$0.42+35.7%
    7d ago-$0.40+32.5%
    Current-$0.27
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Next Report

    CRVO has an expected report date of Mar 11, 2027.

    Earnings History

    Of the 29 quarters below that had an estimate, CRVO beat 11, missed 17 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 168.42% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.39-$0.61-$0.73 - -$0.23+36.07%BeatN/A53 up, 1 downNov 6, 2026N/A
    Jun 30, 2026-$0.64-$0.87-$0.98 - -$0.74+26.44%BeatN/A51 up, 3 downAug 7, 2026N/A
    Mar 31, 2026-$0.86-$0.79-$0.99 - -$0.17-8.46%MissN/A70 up, 3 downMay 18, 2026N/A
    Dec 31, 2025-$0.88-$0.70-$0.89 - -$0.07-25.71%MissN/A60 up, 2 downMar 13, 2026$8726
    Sep 30, 2025-$0.84-$0.64-$0.87 - -$0.06-31.25%MissN/A60 up, 1 downNov 7, 2025$322569
    Jun 30, 2025-$0.70-$0.62-$0.76 - -$0.39-12.90%MissN/A53 up, 0 downAug 8, 2025$1.76M
    Mar 31, 2025-$0.56-$0.62-$0.80 - -$0.47+10.16%BeatN/A6N/AMay 12, 2025$1.92M
    Dec 31, 2024-$0.80-$0.63-$0.72 - -$0.38-26.98%MissN/A7N/AMar 17, 2025$2.16M
    Sep 30, 2024-$0.55-$0.41-$0.50 - -$0.31-34.15%Miss-184.6%40 up, 0 downNov 12, 2024$1.94M
    Jun 30, 2024-$0.27-$0.29-$0.44 - -$0.01+6.90%BeatN/A50 up, 0 downAug 9, 2024$3.29M
    Mar 31, 2024-$0.41-$0.32N/A-28.13%MissN/AN/A0 up, 0 downMay 14, 2024$2.35M
    Dec 31, 2023-$0.38-$0.29N/A-31.03%MissN/A10 up, 0 downMar 25, 2024$2.49M
    Sep 30, 2023$0.65-$0.95N/A+168.42%BeatN/AN/AN/ANov 13, 2023$1.53M
    Jun 30, 2023-$1.55-$1.93N/A+19.64%BeatN/AN/AN/AAug 8, 2023$1.72M
    Mar 31, 2023-$2.01-$1.91N/A-5.24%MissN/AN/A0 up, 0 downMay 15, 2023$1.41M
    Dec 31, 2022-$2.00-$2.22N/A+9.91%BeatN/AN/A0 up, 0 downMar 21, 2023N/A
    Sep 30, 2022-$2.06-$2.06N/A0.00%In lineN/AN/AN/ANov 14, 2022N/A
    Jun 30, 2022-$3.09-$3.06N/A-0.99%MissN/AN/AN/ASep 28, 2022N/A
    Mar 31, 2022-$3.33-$1.75N/A-90.29%MissN/AN/AN/AJun 28, 2022N/A
    Dec 31, 2021-$2.25-$2.00N/A-12.50%MissN/AN/AN/AMar 29, 2022N/A
    Sep 30, 2021-$9.00-$0.04N/AN/AN/AN/AN/AN/ADec 29, 2021N/A
    Jun 30, 2021-$3.00-$3.37N/A+11.11%BeatN/AN/AN/ASep 28, 2021N/A
    Mar 31, 2021-$4.50-$0.05N/AN/AN/AN/AN/AN/AMay 7, 2021N/A
    Dec 31, 2020-$4.50-$4.12N/A-9.10%Miss-121.4%N/AN/AMar 31, 2021N/A
    Sep 30, 2020-$5.25-$4.12N/A-27.28%MissN/AN/AN/ANov 12, 2020N/A
    Jun 30, 2020-$7.50-$0.06N/AN/AN/AN/AN/AN/AAug 10, 2020N/A
    Mar 31, 2020-$5.25-$4.50N/A-16.67%MissN/AN/AN/AMay 11, 2020N/A
    Dec 31, 2019$21.00-$0.14N/AN/AN/AN/AN/AN/AMar 17, 2020N/A
    Sep 30, 2019-$45.00-$53.25N/A+15.49%BeatN/AN/AN/ANov 11, 2019N/A
    Jun 30, 2019-$47.25-$45.00N/A-5.00%MissN/AN/AN/AAug 8, 2019N/A
    Mar 31, 2019-$60.75-$68.25N/A+10.98%Beat-16086.8%N/AN/AMay 9, 2019N/A
    Dec 31, 2018-$124.50-$96.00N/A-29.69%MissN/AN/AN/AMar 31, 2019N/A
    Sep 30, 2018-$146.25-$0.90N/AN/AN/A-73225.0%N/AN/ADec 29, 2018N/A
    Jun 30, 2018-$56.25-$67.46N/A+16.62%BeatN/AN/AN/AAug 13, 2018N/A
    Mar 31, 2018$0.38-$0.04N/AN/AN/AN/AN/AN/AApr 3, 2018N/A
    Sep 30, 2017$0.20N/AN/AN/AN/AN/AN/AN/ADec 29, 2017N/A
    Jun 30, 2017-$0.54N/AN/AN/AN/AN/AN/AN/AAug 21, 2017N/A
    Mar 31, 2017-$1.77N/AN/AN/AN/AN/AN/AN/AMay 15, 2017N/A
    Dec 31, 2016Not reportedN/AN/AN/ANot reportedN/AN/AN/AMar 31, 2017N/A
    Sep 30, 2016-$7.95N/AN/AN/AN/AN/AN/AN/ADec 29, 2016N/A
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$2.98, after -$2.03 the year before. It was -$12,271.14 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$2.98N/A
    Dec 31, 2024-$2.03N/A
    Dec 31, 2023-$3.29N/A
    Dec 31, 2022-$10.48N/A
    Dec 31, 2021-$18.75N/A
    Dec 31, 2020-$22.50N/A
    Dec 31, 2019-$132.00N/A
    Dec 31, 2018-$328.73N/A
    Dec 31, 2016-$1,125.57N/A
    Dec 31, 2015-$12,271.14N/A

    Frequently Asked Questions About CRVO

    When is CervoMed's next earnings date?

    CervoMed's next earnings report is expected for Mar 11, 2027.

    Did CRVO beat earnings estimates last quarter?

    Yes. CervoMed reported EPS of -$0.39 for the quarter ended Sep 30, 2026, above the -$0.61 estimate, a 36.07% surprise.

    What EPS do analysts expect from CRVO next quarter?

    The consensus EPS estimate for CervoMed for the quarter ending Dec 31, 2026 is -$0.53 from 8 analysts, with estimates from -$0.74 to -$0.43.

    How often does CRVO beat earnings estimates?

    CervoMed beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -4.08%.